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Abstract
Certain Major Histocompatibility-I (MHC-I) types are associated with superior immune con-
tainment of HIV-1 infection by CD8+ cytotoxic T lymphocytes (CTLs), but the mechanisms
mediating this containment are difficult to elucidate in vivo. Here we provide controlled
assessments of fitness landscapes and CTL-imposed constraints for immunodominant epi-
topes presented by two protective (B*57 and B*27) and one non-protective (A*02) MHC-I
types. Libraries of HIV-1 with saturation mutagenesis of CTL epitopes are propagated with
and without CTL selective pressure to define the fitness landscapes for epitope mutation
and escape from CTLs via deep sequencing. Immunodominant B*57- and B*27- present
epitopes are highly limited in options for fit mutations, with most viable variants recognizable
by CTLs, whereas an immunodominant A*02 epitope-presented is highly permissive for
mutation, with many options for CTL evasion without loss of viability. Generally, options for
evasion overlap considerably between CTL clones despite highly distinct T cell receptors.
Finally, patterns of variant recognition suggest population-wide CTL selection for the A*02-
presented epitope. Overall, these findings indicate that these protective MHC-I types yield
CTL targeting of highly constrained epitopes, and underscore the importance of blocking
public escape pathways for CTL-based interventions against HIV-1.
Author summary
Certain MHC class I types are associated with superior immune containment of HIV-1,
underscoring the importance of CD8+ cytotoxic T lymphocytes (CTLs). Epitope escape
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mutations for these types is limited, indicating reduced immune evasion. Two proposed
mechanisms are: 1) CTL targeting of highly sequence-constrained epitopes, or 2) more
promiscuous CTLs for epitope variation. However, the in vivo complexity of undefined
starting virus, multiple targeted epitopes, polyclonal CTL responses against each epitope,
and post-hoc evaluation of the interaction renders examination of mechanisms difficult.
Here we approach this question with controlled prospective in vitro experiments using
saturation mutagenesis of epitopes in clonal HIV-1, propagated in the absence or presence
of CTL clones to define the options for epitope mutation and immune evasion by deep
sequencing. We find that two immunodominant epitopes presented by protective MHC
types are highly mutation-constrained compared to one presented by a non-protective
MHC type, whereas CTL promiscuity for epitope variation is not appreciably different.
These results suggest that these protective MHC types are associated with limited HIV-1
escape predominately due to intrinsic constraints on epitope mutation, and underscore
the importance of focusing the CTL response on highly conserved epitopes for immuno-
therapies and vaccines.
Introduction
HIV-1-specific CD8+ cytotoxic T-lymphocytes (CTLs) play a significant protective role in the
pathogenesis of HIV-1 infection [1–3], but ultimately fail to prevent disease progression in
most persons. Myriad failure mechanisms have been proposed, but given the remarkable
mutation rate and sequence plasticity of HIV-1 [4,5], the major factor is viral epitope escape
mutation resulting in a cascade of viral persistence, CTL exhaustion, dysfunction, and senes-
cence in chronic infection [6]. Indeed, evasion of CTLs is the major determinant of viral evolu-
tion in vivo [7–10]. Moreover, the major histocompatibility complex class I (MHC-I) locus is
the best defined genetic determinant of disease progression rate in genome-wide association
[11–13] and epidemiologic studies [14,15], indicating that MHC-I-associated properties of
CTLs are important determinants of their efficacy.
Several studies of persons with “protective” MHC-I types who contain viremia without
treatment have shown limited variation in targeted epitopes. Some have suggested that these
are limited escape mutations with high fitness costs, based on examination of a few epitope
variants observed in vivo [16–24]. However, the generality and mechanisms behind this obser-
vation are unclear, and the contributions of viral versus immune constraints for HIV-1 escape
from CTLs are incompletely understood. Properties of the targeted epitope could be impor-
tant; HIV-1 sequence plasticity is not uniform and epitopes likely vary in their constraints for
mutation [25]. Alternatively, properties of the CTLs could differ; it has been proposed that the
T cell receptors (TCRs) associated with protective MHC-I types either have greater cross-reac-
tivity for epitope mutants and thus better limit possibilities for escape [26–28], or rather are
better matched to common epitope variants [29]. Thus it is unresolved whether the limited
escape is due to properties of the epitopes versus CTLs.
Finally, CTL responses against a given epitope are generally comprised of multiple clones
with differing TCRs [30,31]. Because individual clones recognizing the same epitope can vary
in the recognition of different variants [32–34], it has been proposed that clonal breadth may
be important for preventing escape [30], but protective MHC-I types do not appear to yield
greater TCR breadth overall [31]. This suggests qualitative differences in the composition or
function of TCRs, and it is unclear to what degree the constraints for HIV-1 to escape CTLs
are shared (“public escape”) versus specific for each clone (“private escape”).
Fitness landscapes of HIV-1 epitopes presented by protective MHC types
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Such issues are difficult to address in vivo, where the CTL response is polyclonal, the
starting sequences of HIV-1 are typically undefined, and it is impossible to normalize selec-
tive pressure between epitopes. Here we assess the effect of HIV-1-specific CTLs on the fit-
ness landscape of viral epitope mutation at clonal resolution. Libraries of HIV-1 epitope
mutants are propagated under selective pressure to define the options for immune escape
for multiple CTL clones associated with protective and non-protective MHC-I types,
addressing these issues with an experimentally controlled approach to reveal CTL escape
pathways for HIV-1.
Results
Construction of HIV-1 epitope libraries
Saturation mutagenesis was applied to three immunodominant HIV-1 epitopes in Gag
(Table 1): SLYNTVATL (SL9, Gag 77–85, A02-restricted), KAFSPEVIPMF (KF11, Gag
162–172, B57-restricted), and KRWIILGLNK (KK10, Gag 263–272, B27-restricted).
Degenerate nucleotide DNA synthesis was utilized for each codon encoding the epitope and
its flanking amino acids, as well as every combination of two codons, followed by substitu-
tion into the whole proviral genome of HIV-1 strain NL4-3 (Fig 1). The resulting plasmid
libraries were found by deep sequencing to contain a full representation (100% for each epi-
tope) of single amino acid variants and partial representation of double amino acid variants
(38 to 43%) achieving the threshold frequency of 2.5x10-5 that was considered adequate for
detectable virus production after transfection (Table 2). As expected, the consensus epitope
sequence was overrepresented in each library because consensus amino acids were included
in every degenerate codon (Fig 2A). These proviral DNA libraries were transfected into pro-
ducer cells to yield starting virus libraries after a week of expansion. Deep sequencing of
viral RNA in these libraries again demonstrated that the consensus epitope variant was pre-
dominant, but also demonstrated that a minority of the adequately represented variants in
the plasmid library persisted as replication-competent variants (Table 2 and Fig 2A), sug-
gesting that most epitope mutations were deleterious (36.4 to 86.6% of single codon mutants,
99.12 to 99.97% of double codon mutants). Epitope variants with a threshold frequency
<10−4 in two experimental replicates of virus libraries were considered to be nonviable,
because they tended to decay if present in only one library, indicating insufficient replicative
capacity.
Table 1. HIV-1 epitopes and CTL clones.
Epitope
(Abbreviation)
Gag Amino Acids
(HXB2)
MHC-I Restriction CTL Clone Designationa TRBV CDR3 Sequence TRBJ
SLYNTVATL
(SL9)
77–85 A*0201 S00001-SL9-3.23T 11–2 CASSLEHEQYF 2–7
S00031-SL9-10.11T 12–3*01 CASSWEISDGYTF 1–2*01
S00036-SL9-1.9 5–1*01 CASSFDSEQYF 2–7*01
KAFSPEVIPMF
(KF11)
162–172 B*5701 S00014-KF11-10.6 15*02 CATSGTEYGYTF 1–2*01
S00094-KF11-3.4 5–8*01 CASSVGFGANVLTF 2–6*01
KRWIILGLNK
(KK10)
263–272 B*2705 S00076-KK10-10.37 27*01 CASREGQGALEQYF 2–7*01
S00048-KK10-TCR5 7–9*03 CASSFDAGEQFF 2–1*01
aThe underlined portion of the clone designation is utilized as an abbreviation throughout this study.
https://doi.org/10.1371/journal.ppat.1006541.t001
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Selection of epitope variants by CTL clones
To investigate the properties of the epitope variants, each library was passaged in the absence
and presence of CTLs (Table 1) that had been confirmed to have antiviral activity in virus sup-
pression assays (S1 Fig). Epitope sequences were obtained by deep sequencing at baseline and
after each of two serial passages of one week each (S2 Fig). Significant shifts in the frequencies
of epitope variants within a library occurred in the absence of CTLs, reflecting replicative
capacity differences between variants (Fig 2A). Library propagation with the addition of epi-
tope-targeted CTLs yielded distinctly different profiles of epitope variants, indicating superim-
posed selective pressure by the CTLs (Fig 2B). Control CTLs targeting an irrelevant epitope
did not induce a profile distinct from passaging without CTLs, and the magnitude of the epi-
tope-specific CTL-induced change was dose-dependent (Fig 2C). The small minority of vari-
ants containing stop codons that achieved the detectable threshold in the initial virus libraries
generally showed sharply decaying frequencies (S3 Fig), confirming the reflection of replicative
capacity. The outcome for each epitope variant was quantified as a relative enrichment value
(RE) compared to the subtype B consensus epitope sequence, calculated as the log10 trans-
formed ratio of frequencies normalized to subtype B consensus variant (Fig 2D) in the absence
or presence of CTLs (RE-CTL and RE+CTL respectively). Thus RE-CTL values reflected intrinsic
replicative capacity relative to the consensus variant, with values <0 and >0 indicating vari-
ants replicating less and more efficiently (relative to the consensus variant) respectively.
RE+CTL values reflected the impact of CTL selection relative to the consensus variant, indepen-
dently of replicative capacity (e.g. a variant with RE-CTL<0 and RE+CTL>0 indicates that it rep-
licates less efficiently and is less suppressed by CTL than consensus). The REs between
experimental replicates were highly correlated (Fig 2E and 2F), demonstrating the robustness
of this measurement. Two separately produced virus libraries were utilized for all further
determinations of RE-CTL and RE+CTL values, which were calculated as averages of quadrupli-
cates (duplicate virus libraries each passaged in duplicate without CTLs) and duplicates (dupli-
cate virus libraries each passaged singly with CTLs) respectively.
Fig 1. Production of HIV-1 epitope mutant virus libraries. Double-stranded DNA encoding an HIV-1
genomic region including an epitope of interest was synthesized to represent every possible single and double
amino acid variant within the epitope and its immediately flanking amino acids, using degenerate codons
(NNK, where N is any nucleotide and K is guanine or thymidine, encoding every amino acid while reducing
stop codons). This DNA was then substituted into the full length HIV-1 NL4-3 genome to create a plasmid
HIV-1 library for virus production.
https://doi.org/10.1371/journal.ppat.1006541.g001
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Consistent patterns of epitope selection are seen in the absence and
presence of CTL selective pressure
The impacts of mutations at each epitope amino acid position were evaluated by examining
the subsets of single codon mutants in each library (Figs 3–5). Passaging in the absence of
CTLs revealed the effects of point mutations on intrinsic viral replication. For each epitope,
most mutations had negative effects on replication (RE-CTL<0). However, each epitope also
demonstrated mutations that were tolerated or advantageous (RE-CTL0). For SL9, substitu-
tions at multiple positions yielded enrichment, particularly at residues -1, 5, and 8 of the epi-
tope (Fig 3 “No CTL” panel). KF11 appeared to have fewer tolerated mutations (Fig 4 “No
CTL” panel), mostly at residues 2 and 4, while KK10 (Fig 5 “No CTL” panel) had several tol-
erated mutations mostly at residues 2, 5, and 6. Evaluation of these epitopes under additional
CTL selection also demonstrated patterns of epitope enrichment relative to the consensus
epitope sequences (RE+CTL >0). The addition of CTL generally appeared to augment enrich-
ment of epitope variants with intrinsic growth advantages in the absence of CTLs (Figs 3–5),
although there were also some intrinsically disadvantageous variants that gained enrichment
with the addition of CTLs. Conversely, some intrinsically advantageous variants were
selected against with the addition of CTLs, particularly those with substitutions at the -1
position of the SL9 epitope. The net effect of CTL selection (ΔRE = RE+CTL- RE-CTL) was
examined for each epitope variant (Fig 6). The relevance of this value to identify potential
CTL escape variants was confirmed by generating HIV-1 clones corresponding to library
variants with defined ΔRE values, and testing their susceptibility to inhibition of replication
by CTLs (Fig 7). Thus this parameter showed that many single substitutions conferred bene-
fits against CTL selection (Fig 6). A major exception was the N-terminal flanking amino acid
of the SL9 epitope (position -1), where most substitutions increased susceptibility to CTLs.
Overall, these data demonstrate epitope-specific constraints for mutation and evasion of
CTLs.
Table 2. Epitope variants contained in plasmid and virus libraries.
Epitope Codon Mutants Possible In Plasmid Library In Virus Library Replicating
SL9 Single 209 209 77 36.8%
Double 19,855 8,505 75 0.88%
Both 20,064 8,714 152 1.74%
KF11 Single 247 247 33 13.4%
Double 28,158 10,754 18 0.17%
Both 28,405 10,901 51 0.46%
KK10 Single 228 228 145 63.6%
Double 23,826 9,557 3 0.03%
Both 24,054 9,785 148 1.51%
The number of possible single and double amino acid variants within each library (excluding stop codons) is given, as well as the number of these variants
detected above threshold in the plasmid library ( 2.5x10-5, assumed to be adequate for representation after transfection of producer cells and passaging in
5 x 106 cells thus yielding 20x sampling), and the number that carried forward above threshold ( 10−4 in both biological replicates, assumed to have
replicated after transfection) in the virus libraries. Epitope variants below this frequency tended to decay if present in only one library, and thus were
considered nonviable. If a variant was present above threshold in the plasmid library but inadequately represented in the virus library produced by
transfection of the plasmid library into producer cells, it was also considered to be nonviable.
https://doi.org/10.1371/journal.ppat.1006541.t002
Fitness landscapes of HIV-1 epitopes presented by protective MHC types
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Fig 2. CTL selective pressure results in altered HIV-1 epitope variant frequencies. A. The frequencies of each SL9 epitope variant are plotted for the
plasmid library, initial virus library, and virus populations after one or two weeks of passage (in the absence of CTL selection). All sequences below a
frequency threshold of 2.5x10-5 in the plasmid library (inadequately represented for carry-through to the virus library) are represented in black. The
frequencies of the consensus variant are significantly different between time points (p<0.00001). The subtype B consensus variant of the SL9 epitope is
indicated by the bottom light blue bars in all bar graphs, and color coding of each variant is consistent across panels; variants not achieving the frequency
cutoff of 1x10-4 in both replicates of the starting virus library are labeled “other sequences” and indicated by hatched gray bars. B. The frequencies of
epitope variants after one and two weeks of passaging in the presence of the SL9-specific CTL clone 3.23T are indicated. Again, the consensus variant
Fitness landscapes of HIV-1 epitopes presented by protective MHC types
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KF11 and KK10 escape from CTLs is more constrained than SL9 mostly
due to more limited fitness landscapes for epitope mutation
Quantitative analyses were extended to all epitope variants in the libraries, including double
amino acid mutants (Table 1), to compare epitopes. First examining RE-CTL (Fig 8, S4–S6 Figs
first columns), the SL9 library yielded more variants with neutral to moderately decreased rep-
lication capacity (RE-CTL0 or RE-CTL-0.5) compared to KF11 and KK10, whereas KF11 and
KK10 were similar (Fig 9). There were 30 and 59 (0.34% and 0.68% of all single and double
SL9 mutants adequately represented in the plasmid library) SL9 variants with RE-CTL0 and
-0.5 respectively, compared to 2 and 17 (0.018% and 0.031%) and 3 and 16 (0.16% and 0.16%)
of KF11 and KK10 epitopes reaching those thresholds (Fig 9 top). The distributions of mea-
surements showed increasing numbers of lower RE-CTL variants, consistent with insufficient
replicative capacity for the variants in the plasmid library that were not detected in the virus
library (Fig 9 bottom). Comparing susceptibilities of epitope variants to CTLs (ΔRE), many
variants had neutral to enriched effects under CTL selection (Fig 8). Across all variants in the
virus libraries (excluding variants with mutations in epitope flanking residues, to isolate effects
of changes in CTL epitope recognition from epitope processing), this parameter displayed a
range of values that was normally distributed (Fig 10). The mean ΔRE value across all SL9-spe-
cific CTLs was similar to KF11- and KK10- specific CTLs (1.31 versus 1.54 and 1.32 respec-
tively), although the percentages of variants with at least 5-fold advantage under CTL selection
(ΔRE0.7) was significantly higher (92.9% versus 78.1% and 74.8% respectively, Fig 10 top).
Over the range of 2-to 10-fold relative enrichment with CTLs, a stable profile of selected vari-
ants was observed (S4-S6 third columns), and thus 5-fold selection (ΔRE0.7) was chosen as a
definition of potential escape. Finally, considering the numbers of potential escape variants
under this definition with at least moderate replicative capacity (RE-CTL-0.5) as viable
options for escape, SL9 had significantly more options than KF11 or KK10. Using mean values
across CTLs, SL9 had 19 variants (0.22% of variants in the virus library) compared to 4
(0.036%) and 3 (0.031%) variants for KF11 and KK10 respectively meeting these criteria (Fig
11). In summary, the SL9 epitope offers more options for viable mutations than KF11 or
KK10, and average CTL coverage of those mutations is similar or perhaps modestly decreased
for SL9 compared to KF11 and KK10 (Fig 12).
Different CTL clones targeting each epitope overlap considerably in escape muta-
tions. To address the similarity of epitope variant recognition between differing CTL clones,
the ΔRE values for clones were compared (Fig 13). In general, CTL susceptibilities of variants
were highly correlated for SL9, KF11, and KK10 epitopes, with few exceptions. Overall, these
data suggest that most potential escape mutations for each epitope are shared across different
CTL clones (representing “public” options).
Discussion
This study addresses the fitness landscape for mutational variation of three HIV-1 epitopes
and the restrictions imposed by CTLs. While in vivo observations have revealed the effects of
differs significantly between time points (p<0.00001), and additionally significantly different (p<0.00001) between libraries cultured without versus with
3.23T after 1 and 2 weeks. C. Epitope variant frequencies are plotted after one week of passaging in the presence of a control CTL clone 68A62
recognizing an A*02-restricted epitope in reverse transcriptase, or different effector to target (E:T) ratios of clone 3.23T. The frequencies of the consensus
variant are significantly different (p<0.00001) between culture with 68A62 versus 3.23T. D. The formula to calculate relative enrichment (RE) of each
variant compared to the subtype B consensus epitope variant using the frequency of each variant compared to the consensus epitope is shown. E and F.
The REs between two biological replicate experiments with the SL9 variant library passaged in the absence (E) or presence (F) of clone 3.23T (RE
-CTL
values without CTLs and RE+CTL values with CTLs respectively) are plotted. Red dots in both panels E and F indicate variants with high RE+CTL values,
demonstrating their locations in the RE
-CTL plot. All panels are representative of individual replicate experiments.
https://doi.org/10.1371/journal.ppat.1006541.g002
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Fig 3. Single amino acid epitope variants display distinct patterns of selection in the absence or
presence of CTLs (SL9 epitope). The RE values of all single amino acid variants with or without addition of
the indicated CTL clones are displayed as color-scaled boxes. The horizontal axis indicates each subtype B
consensus amino acid of each epitope and its immediately flanking amino acids, and the vertical axis
indicates substituting amino acids. Hatched boxes indicate consensus amino acids. Additionally, the mean
REs for substitutions of amino acids that are hydrophobic (A, V, I, L, M, F, Y, W, G, and P), polar-noncharged
(C, S, T, N, and Q), basic (R, H, K), or acidic (D and E) are indicated below each plot. Variants that were
Fitness landscapes of HIV-1 epitopes presented by protective MHC types
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CTL on viral evolution to escape, our data dissect this process in greater detail, resolving the
interaction at the level of individual CTL clones and defined starting virus quasispecies popula-
tions. For each epitope, the effect of every single amino acid polymorphism (as well as about a
third of all double amino acid polymorphisms) versus the subtype B consensus sequence is
assessed by frequency change as a reflection of fitness during serial passaging, as well as the
impact of clonal CTL selection on these variants. Two epitopes presented by protective MHC-I
types B57 (KF11) and B27 (KK10) and an epitope presented by the non-protective type A02
(SL9) are examined in detail.
The quantities of mutation options in the absence of CTL selection markedly differ between
these epitopes. The SL9 epitope exhibits many variants with similar or higher fitness compared
to consensus, whereas KF11 and KK10 epitopes appear to have very few. This finding indicates
that the SL9 epitope is much less constrained for mutation than KF11 and KK10, suggesting
that HIV-1 generally has fewer options for mutational escape in KF11 and KK10 (Gag p24)
than SL9 (Gag p17) epitopes. This result agrees with prior observations that: efficient immune
containment of HIV-1 corresponds to CTL targeting of p24 [35], that immunodominance of
p24 targeting is commonly associated with protective MHC-I types (including B57 and B27)
[36,37], and that p24 is highly conserved overall [25]. However, studies delineating associa-
tions of particular CTL responses with immune containment of HIV-1 demonstrate that pro-
tective epitope targeting is not limited to p24 [37,38], suggesting that sequence constraint at
the level of the individual epitope overrides the particular source protein in importance for
escape and thus CTL efficacy.
The epitope variants that were enriched under CTL selection further illuminate the con-
straints for escape mutation. For SL9, there are several highly CTL-enriched variants with
intrinsic fitness near the consensus epitope. In contrast, KF11 and KK10 both exhibit few
CTL-enriched variants with preserved fitness, in agreement with prior studies showing that
CTL escape mutations for these epitopes require high fitness costs [16–19,21–24]. Moreover,
the variants enriched by CTL selection recapitulate several previously reported escape variants
in vivo, such as Y79F in SL9 [16] and A163G in KF11 [18], although some other reported
escape variants such as KF11 A163G/S165N [18] were present in the initial plasmid library but
appeared replication incompetent. As a whole, these data support the concept that protective
MHC-I types such as B27 and B57 are beneficial through generating CTL responses against
epitopes for which escape occurs only at a high fitness cost to HIV-1.
Regarding the alternative hypothesis that protective MHC-I types yield TCRs with greater
promiscuity for epitope variation [26–28], our findings do not provide definitive evidence.
While KF11- and KK10- specific CTLs do appear to recognize more variants on average than
SL9-specific CTLs, the average impacts of CTLs on epitope variants do not vary significantly
between epitopes. However, these measurements are limited to CTL interactions only with via-
ble variants, and are thus not a comprehensive evaluation of promiscuity across all epitope var-
iation. Within the subset of viable mutants, there is no clear difference in coverage by CTLs
across the three epitopes, and the findings are consistent with a study suggesting that better
immune containment of HIV-1 is mediated by CTL responses that are more focused on viable
epitope variants despite recognizing fewer epitope variants overall [29].
An unexpected finding is that CTL recognition of SL9 is enhanced by various substitutions
at the N-terminus flanking amino acid. This suggests that these substitutions increase epitope
presentation compared to the consensus sequence. Although the influence of various
detected above threshold in the plasmid library but not in the virus library were considered non-replicating and
assigned RE
-CTL = -2.0 for these analyses.
https://doi.org/10.1371/journal.ppat.1006541.g003
Fitness landscapes of HIV-1 epitopes presented by protective MHC types
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Fig 4. Single amino acid epitope variants display distinct patterns of selection in the absence or
presence of CTLs (KF11 epitope). The RE values of all single amino acid variants with or without addition of
the indicated CTL clones are displayed as color-scaled boxes. The horizontal axis indicates each subtype B
consensus amino acid of each epitope and its immediately flanking amino acids, and the vertical axis
indicates substituting amino acids. Hatched boxes indicate consensus amino acids. Additionally, the mean
REs for substitutions of amino acids that are hydrophobic (A, V, I, L, M, F, Y, W, G, and P), polar-noncharged
(C, S, T, N, and Q), basic (R, H, K), or acidic (D and E) are indicated below each plot. Variants that were
detected above threshold in the plasmid library but not in the virus library were considered non-replicating and
assigned RE
-CTL = -2.0 for these analyses.
https://doi.org/10.1371/journal.ppat.1006541.g004
Fitness landscapes of HIV-1 epitopes presented by protective MHC types
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Fig 5. Single amino acid epitope variants display distinct patterns of selection in the absence or
presence of CTLs (KK10 epitope). The RE values of all single amino acid variants with or without addition of
the indicated CTL clones are displayed as color-scaled boxes. The horizontal axis indicates each subtype B
consensus amino acid of each epitope and its immediately flanking amino acids, and the vertical axis
indicates substituting amino acids. Hatched boxes indicate consensus amino acids. Additionally, the mean
REs for substitutions of amino acids that are hydrophobic (A, V, I, L, M, F, Y, W, G, and P), polar-noncharged
(C, S, T, N, and Q), basic (R, H, K), or acidic (D and E) are indicated below each plot. Variants that were
detected above threshold in the plasmid library but not in the virus library were considered non-replicating and
assigned RE
-CTL = -2.0 for these analyses.
https://doi.org/10.1371/journal.ppat.1006541.g005
Fitness landscapes of HIV-1 epitopes presented by protective MHC types
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mutations within the SL9 epitope reducing its proteasomal processing and presentation have
been demonstrated [39], the impairment of processing associated with the N-terminus flank-
ing residue in the consensus sequence has not been reported. Given the high prevalence of
A02 and the capacity of other MHC-I types such as B40 to present the SL9 epitope, it is plau-
sible that the consensus sequence represents escape adaptation across the human population.
Also unexpected is the observation that several SL9 epitope variants had apparently higher fit-
ness than the consensus sequence. Both these findings support the proposal that HIV-1 can
accumulate escape mutations in the consensus sequence for circulating strains, as has been
suggested specifically for SL9 [40] and more generally across the HIV-1 genome [7,8].
We previously reported the differential ability of CTL clones targeting the same epitope to
cross-recognize escape variants [32–34]. Here we confirm such differences between clones, but
find that the overall options for escape are strikingly similar even between TCRs with entirely
Fig 6. Identification of single amino acid epitope variants that potentially escape from CTLs. The net changes in RE values due to CTL selection
(ΔRE = RE+CTL—RE-CTL) are displayed as color-scaled boxes for all single amino acid variants of epitopes SL9 (A), KF11 (B), and KK10 (C). The
horizontal axis indicates each subtype B consensus amino acid and its immediately flanking amino acids, and the vertical axis indicates substituting amino
acids. Variants that detected above threshold in the plasmid library but not in the virus library are considered non-replicating and coded by dark grey.
Consensus amino acids are coded by hatched boxes.
https://doi.org/10.1371/journal.ppat.1006541.g006
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different variable chains. For each epitope, the amino acid substitutions resulting in CTL eva-
sion follow stereotypic patterns mostly sparing the main MHC-I anchor-binding residues.
Although such substitutions could affect proteasomal processing, epitope stability, or MHC-I
binding, this suggests shared mutational pathways for ablating binding of sequence-distinct
TCRs, and that these “public escape” pathways may predominate for these epitopes, consistent
with prior population-based studies of HIV-1 escape “footprints” in vivo [8,41].
Several caveats must be considered for the interpretation of our data. Our libraries provide
complete coverage for single amino acid polymorphisms in the epitopes, but incomplete cov-
erage for double amino acid polymorphisms, and no coverage for three or more changes.
However, most reported escape mutations are single or double polymorphisms compared to
consensus, and our data show sharply decreased viability for double mutants compared to sin-
gle mutants, suggesting that very few triple mutants would be viable. The RE values for epitope
variants are semiquantitative reflections of HIV-1 fitness, given the saturating conditions for
viral growth that can exaggerate the competitive advantage of the most fit variants. Moreover,
the selective pressure exerted by CTLs is dependent on the experimental conditions, i.e. the
number of added cells and functional activity of the cells. While these parameters are kept as
constant as possible between experiments, there is biologic variability that is difficult to control
entirely; thus setting RE values based on consensus sequence epitopes provides a frame of ref-
erence for comparisons between different experiments and SL9, KF11, and KK10 epitopes,
because HIV-1 with consensus sequences in all three epitopes is shared between all libraries.
Finally, fitness costs for sequence polymorphisms can vary considerably in different genomic
Fig 7. Confirmation thatΔRE values reflect potential for escape from CTLs. Clonal HIV-1NL4-3 with five
SL9 epitope variants with increased (1.39–1.66 and 1.37–2.32 for CTL clones 3.23T and 10.11T
respectively), one variant with decreased (-1.42 and -1.43 with CTL clones 3.23T and 10.11T respectively)
ΔRE, and the subtype B consensus epitope were individually tested for susceptibility for suppression by
CTLs. T1 cells were acutely infected and cultured in the presence or absence of CTL clones 3.23T or 10.11T;
supernatant p24 antigen values after 7 days are plotted for each indicated variant. Each value is the mean of
triplicates, and error bars represent standard deviations.
https://doi.org/10.1371/journal.ppat.1006541.g007
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Fig 8. CTL selection of all library epitope variants. The RE values of all epitope variants with or without addition of the indicated CTL clones are
displayed as color-scaled boxes for epitopes SL9, KF11, and KK10. The horizontal axis indicates each consensus amino acid and its immediately flanking
amino acids, and the vertical axis indicates substituting amino acids. First columns indicate relative enrichment versus consensus variant without CTLs
(RE
-CTL), second columns indicate relative enrichment versus consensus variant with added CTLs (RE+CTL), third columns indicate the difference between
those values (ΔRE = RE+CTL-RE-CTL), and fourth columns indicate variants with ΔRE 0.7 = 5-fold (white boxes) or < 0.7 (gray boxes). Variants with RE-
CTL < -1.5 and stop codons are omitted.
https://doi.org/10.1371/journal.ppat.1006541.g008
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contexts, and our results in HIV-1 strain NL4-3 using single epitope targeting may not reflect
the outcome for different virus with CTL pressure on multiple epitopes simultaneously.
Related to this point is the inability to assess for compensatory mutations. However, the gen-
eral patterns we observe are striking, and provide insight into the overall levels of constraints
for these epitopes.
Fig 9. Distributions of epitope variant viabilities. Top panel: The mean RE
-CTL values of all variants in the
virus library are plotted for each epitope. The numbers achieving thresholds of RE
-CTL0 and RE-CTL-0.5
and their frequencies (over all variants adequately represented in the plasmid library) are indicated for each
epitope. Variants with RE
-CTL<-2 are not plotted. Bottom panel: The numbers of variants in different ranges of
mean RE
-CTL values are indicated.
https://doi.org/10.1371/journal.ppat.1006541.g009
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In summary, our findings indicate that two immunodominant epitopes associated with
protective MHC-I types have highly restricted fitness landscapes for mutation compared to
one that is not associated with protection, and that this allows very limited options for escape
from CTLs. Additionally, most escape pathways appear to be public and shared between differ-
ent clones recognizing these epitopes. These results have implications for harnessing CTL
responses as vaccines and/or immunotherapies. An early attempt at therapeutic adoptive
transfer of CTLs resulted in rapid viral escape [42], and analysis of the failed Step trial demon-
strated a “sieve” effect in infected individuals, reflecting viral escape from vaccine-induced
CTLs [43]. Thus, a successful CTL-based approach will require understanding of the
Fig 10. CTL promiscuity for epitope variant recognition. Top panel: The mean ΔRE values of all variants
in the virus library are plotted for each epitope, excluding those with mutations in the epitope flanking residues.
The numbers and frequencies (over all variants adequately represented in the virus library) of variants
achieving a threshold of ΔRE0.7 are indicated. Bottom panel: The numbers of variants in different ranges of
mean ΔRE values are indicated.
https://doi.org/10.1371/journal.ppat.1006541.g010
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constraints for escape and strategies to block HIV-1 escape routes through reducing HIV-1
options for mutational escape and/or increasing CTL coverage of mutation options.
Materials and methods
Epitope mutational libraries of plasmid HIV-1 NL4-3
Double-stranded DNA spanning the Gag epitope regions of interest were commercially syn-
thesized (gBlock, Integrated DNA Technologies, Coralville, IA) using NNK degenerate codons
(where “N” is any nucleotide, and “K” is guanine or thymidine) at each single or double codon
position for the epitope and its flanking codons. These gBlock DNA fragments were then PCR
Fig 11. Comparisons of viabilities of potential escape variant epitopes for SL9, KF11, and KK10. Top
panel: RE
-CTL values are plotted for all SL9, KF11, and KK10 epitope variants (excluding those with
substitutions in flanking residues) in the virus libraries. Potential escape variants (ΔRE0.7) are indicated by
filled symbols, and the remainder are open symbols. Bottom panel: RE
-CTL values are plotted for all SL9,
KF11, and KK10 epitope variants as above, where variants with mean ΔRE0.7 for all tested CTLs are
indicated by filled symbols. Numbers of potential escape variants with RE
-CTL>-0.5 and their frequencies
among variants in the virus libraries are indicated.
https://doi.org/10.1371/journal.ppat.1006541.g011
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amplified using primers 5’-ATCTCTAGCAGTGGCGCCC-3’ with 5’-TTTGGCTGACCTG
GCTGTTG-3’ for the fragment containing the SLYNTVATL (Gag 77–85, SL9) epitope, and
5’-AGACACCAAGGAAGCCTTAGATAAGA-3’ with 5’-TACCTCTTGTGAAGCTT
GCTCG-3’ for the fragments containing the KAFSPEVIPMF (Gag 162–172, KF11) and
KRWIILGLNK (Gag 263–272, KK10) epitopes. These primer sequences corresponded to the
start and end sequences of the synthesized DNA fragments. A modified HIV-1 NL4-3 provirus
plasmid was created to reduce LTR-driven recombination during cloning, with 5’ U3 and 3’
U5 regions of the HIV LTR removed (to reduce LTR homology), flanked by the CMV immedi-
ate-early promoter and the BGH polyA sequence (Fig 1). Additionally, this vector was modi-
fied to delete the synthesized epitope regions except the first and last 15 nucleotides; the
junction of the deleted regions were modified to have blunt cutting restriction enzyme sites:
Fig 12. Schematic representation of fitness landscapes and CTL escape options for SL9, KF11, and
KK10. Epitope variants (including the immediate flanking residues) with mean ΔRE0.7 were considered
potential escape variants, and RE
-CTL-0.5 were considered viable. The percentages of viability and
susceptibility to CTLs for double amino acid variants that were missing in our plasmid library were inferred to
be the same as those that were present and tested in this study. Top row: Venn diagrams indicate total
numbers of possible single and double amino acid variants (white circles), numbers of viable variants (red
circles), and numbers of viable variants susceptible to CTLs (green circles). The surface areas of each circle
are approximately proportional to the numbers of variants contained. Bottom panel: Bar graphs indicate the
same data, where gray bars indicate non-viable variants, green bars indicate viable variants that are
recognized by CTLs, and red bars indicate viable variants that escape CTLs.
https://doi.org/10.1371/journal.ppat.1006541.g012
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SfoI for the region containing SL9, AfeI for the region containing KF11 and KK10. After line-
arizing each plasmid vector with the appropriate enzyme, the PCR-amplified gBlock DNA
fragments were inserted via the 15 nucleotide homology by “Infusion” (Clontech, Mountain
View, CA) to created whole genome plasmid libraries. The resulting plasmids were then trans-
formed into Stellar chemocompetent E. coli (Clontech, Mountain View, CA), plated onto
100mm LB/ampicillin plates at ~2x104 colonies/plate and grown for 24 hours at 30˚C. Colo-
nies were collected by washing the bacteria from the plates with Luria broth with ampicillin.
The plasmid DNA isolated from these bacteria served as the initial “plasmid libraries” for each
epitope.
Creation of HIV-1 epitope libraries
The plasmid libraries of each epitope were lipofected into two T75 flasks of 70% confluent
HEK 293T cells (obtained from Dr. Irvin S. Y. Chen, University of California, Los Angeles)
using 20μg DNA with BioT lipofection reagent (Bioland Scientific, Paramount, CA). After 24
hours the media was removed, and 107 T1 cells [44] (obtained from Dr. Bruce D. Walker, Har-
vard University) in 20mL RPMI 1640 medium supplemented with 10% FCS, L-glutamine,
HEPES, and penicillin-streptomycin (R10) were added to each flask to promote cell-cell infec-
tion of the T1 cells. After 24 hours, the nonadherent cells were removed and transferred to a
Fig 13. Correlations of epitope variant susceptibilities to different CTLs targeting SL9, KF11, or KK10
epitopes. The ΔRE values are compared between CTLs targeting targeting each epitope. Shaded areas indicate
ΔRE0.7 for one or both CTLs, and red filled symbols indicate those with RE-CTL-0.5. Epitope variants that were
not detected in the virus libraries (non-replicating) were excluded.
https://doi.org/10.1371/journal.ppat.1006541.g013
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new flask. These cells were then cultured for 6 to 8 days in R10 media until at least 50% of the
cells were infected with HIV-1 (determined by expression of p24 antigen in the cells by intra-
cellular staining and flow cytometry). The supernatant was then filtered through a 0.45 micron
filter and cryopreserved to be utilized as the “starting virus library.” All virus libraries were
produced in duplicate, and all experiments utilized both libraries in parallel, with duplicates
for cultures without CTLs (two replicates for each library, four total) and singles for cultures
with CTLs (one replicate for each library, two total).
HIV-1-permissive cell lines
Cell lines utilized for passaging of HIV-1 included T1[44] (expressing A02 for the SL9 library
and A02-restricted CTLs), 1CC4.14 cells (expressing B57 for the KF11 library and
B57-restricted CTLs, previously produced in our laboratory [45]), and Subject 00076 EBV-
transformed B-cells (previously produced in our laboratory from PBMC) that were transduced
with human CD4 (expressing B27 for the KK10 library and B27-restricted CTLs).
Ethics statement
CTL clones (Table 1) were previously isolated from chronically HIV-1-infected persons and
maintained as previously described [46–48] from blood obtained with written informed con-
sent under a University of California, Los Angeles Institutional Review Board-approved proto-
col, with the exception of 68A62 provided by Dr. Bruce D. Walker (Harvard University).
HIV-1-specific CTL derivation and maintenance
In brief, peripheral blood mononuclear cells (PBMCs) were enriched for the CTLs of interest
by culture with the appropriate epitope, followed by cloning at limiting dilution. Some experi-
ments utilized KK10-specific CTLs previously produced by stable lentiviral transduction of
allogeneic CD8+ T-cells with a KK10-specific T cell receptor (TCR) sequence identified by
quantitative spectratyping [31] (TCR5) that had been cloned into a lentiviral vector as previ-
ously described [34]. CTLs were maintained by periodic stimulation with 200ng/mL of the
monoclonal anti-CD3 12F6 antibody [49] with irradiated allogeneic PBMCs (obtained anony-
mously through the UCLA AIDS Institute Virology Core Facility) in R10 media supplemented
with recombinant human interleukin-2 (NIH AIDS Reference and Reagent Repository) at
50IU/mL (R10-50). For the CTL clones, TCR beta variable (BV) chain sequences were deter-
mined after RNA isolation using Trizol reagent (ThermoFisher Scientific, Waltham, MA),
amplification and cloning of the BV gene using the SMARTER 5’ RACE kit (Clontech, Moun-
tain View, CA) with a constant region primer (5’-CTTCTGATGGCTCAAACAC-3’), and
sequencing using the same primer.
Passaging of virus libraries
5x106 permissive cells (106 cells for the SL9 library passaged with the 1.9 CTL) were infected
with the starting virus library, yielding about 10–20% infected cells after 72–96 hours (deter-
mined by intracellular staining for p24). The cells were then washed twice and resuspended at
5x105 cells/mL in R10-50. CTLs were added at effector:target ratios of 1:8 (except 1:2 for the
SL9 library with CTL 1.9), with parallel no-CTL controls. These cultures were fed every 3 days
by removing and replacing half of the media. After 7 days the supernatant was filtered through
a 0.45 micron filter and cryopreserved; virus in the supernatant was quantified via p24 ELISA
(Xpress Bio, Frederick, MD). This virus was utilized to infect cells for a second passage in the
same manner using 5x103 pg p24 per 106 target cells (103 pg p24 per 106 target cells for the
Fitness landscapes of HIV-1 epitopes presented by protective MHC types
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KK10 library), followed by collection and cryopreservation as before. All passaging with CTLs
was performed with duplicate virus libraries, and passaging without CTLs was done in quadru-
plicate (2 replicates for each virus library).
Deep sequencing of passaged virus libraries
The passaged virus supernatant was treated with DNAse I (New England Biolabs, Ipswich,
MA) to remove residual plasmid DNA. HIV-1 RNA was isolated with the QIAmp viral RNA
mini kit (Qiagen, Hilden, Germany), and reverse-transcribed with the high capacity cDNA
reverse transcription kit (ThermoFisher Scientific, Waltham, MA) and quantified by real-time
PCR with ssoFast EvaGreen supermix on a CFX96 (Bio-Rad, Hercules, CA) with gag-specific
primers (5’-ATCTCTAGCAGTGGCGCCC-3’ and 5’-TTTGGCTGACCTGGCTGTTG-3’)
compared to NL4-3 plasmid standard to ensure5x105 copies/μL of cDNA per specimen.
This cDNA and the starting plasmid libraries were prepared for deep sequencing by PCR
amplification using primers tagged with 6 base-pair customized barcodes. The gene specific
portions of the primers were:
5’-CCATCCCTTCAGACAGGATCAGA-3’ and 5’-AAGGCTTCCTTGGTGTCTTTTAC-3’
for the SL9 libraries,
5’- AGGCCATATCACCTAGAACTTTA-3’ and 5’- CCCACTGTGTTTAGCATGGTATT-3’
for the KF11 libraries, and
5’-TCCACCTATCCCAGTAGGAGAAA-3’ and 5’-GTCCTTGTCTTATGTCCAGAATGC-3’
for the KK10 libraries.
Deep sequencing was performed with Hiseq PE150 sequencing (Illumina, San Diego, CA).
Deep sequencing analyses
The sequence data were parsed using the SeqIO function of open source BioPython software
(http://biopython.org/). Sequences from different samples were de-multiplexed by the bar-
codes and mapped to the corresponding region in the HIV-1 genome. Since both forward and
reverse reads covered the mutated region, paired reads were used to compensate for sequenc-
ing errors. A polymorphism was accepted as valid only if observed in both reads and with a
quality score30. Further filtering for errors was done by comparison to control deep
sequencing of the index NL4-3 plasmid; variants present at a frequency <10−4 were only
accepted if their frequencies in duplicate virus libraries exceeded 10-fold the observed fre-
quency of the variant in the control plasmid sequences (due to background error). The
sequencing depth was >6x105 and>4x106 for the virus and plasmid libraries respectively. All
the data processing and analysis was performed with customized python scripts, which are
available upon request. Variants above threshold in initial virus libraries whose frequencies
decayed to 0 after passaging were assigned a frequency of 10−6 for calculation of RE values. All
sequences have been uploaded to GenBank (PRJNA394927).
HIV-1 clonal mutagenesis of the SL9 epitope
Site-directed mutagenesis was performed with the Q5 mutagenesis kit (New England Biolabs,
Ipswich, MA) on the modified pNL4-3 vector described above, which had been further modi-
fied to contain the M20A mutation that ablates Nef-mediated MHC-I downregulation [50,51].
The SL9 epitope was modified to create variants SLYNAVAVL (codon 4 = GCT, codon
7 = GTG), SLYNTVACL (codon 8 = TGT), SLYITVATL (codon 4 = ATA), SLYNCVACL
Fitness landscapes of HIV-1 epitopes presented by protective MHC types
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(codon 5 = TGT, codon 8 = TGT), SLYCTVATL (codon 4 = TGT), and the resulting plasmids
were lipofected into HEK 293T cells as above to produce virus.
Virus suppression assays
Evaluation of HIV-1 susceptibility to CTL suppression was performed as previously described
[32,48]. Briefly, T1 cells [44] were infected with 500pg p24/106 cells of the indicated viruses,
and 5x104 infected cells with 5x104 CTL (S2 Fig) or 1.25x104 CTL (Fig 9) were cultured in
200μL R10-50 U/ml IL-2 in a 96 well flat-bottom plate, with monitoring of supernatant p24
antigen by ELISA (Xpress Bio, Frederick, MD).
Statistics
Comparisons for correlations of replicate experiments and selection of epitope variants by dif-
ferent CTL clones were performed using Spearman rank correlation. Comparisons of means
of two groups were performed using Student’s t-test. Comparisons of frequencies between two
groups were performed using Fisher’s exact test.
Supporting information
S1 Fig. CTLs utilized in this study suppress HIV-1 replication. T1 cells were infected with
HIV-1 NL4-3.1 (with the subtype B consensus SL9 epitope sequence) and co-cultured with
CTL clone 1.9, followed by monitoring of supernatant p24 antigen. Results are plotted for viral
replication in the presence (closed triangles) or absence (open circles) of CTL co-culture (A).
Results for day 6 or 7 are shown for all CTLs utilized in this study (B). Each value is the mean
of triplicates, and error bars represent standard deviations.
(TIF)
S2 Fig. Schematic describing the passaging of HIV-1 epitope mutant virus libraries under
selective pressure from CTLs. Plasmid libraries created as described in Fig 1 were transfected
into 293T cells to produce starting virus libraries, which were then passaged in the presence or
absence of CTLs for two consecutive rounds of 7 days each. Deep sequencing of the epitope
region was performed for the initial plasmid library and the virus libraries before and after
selective passaging.
(TIF)
S3 Fig. HIV-1 epitope variants with stop codons generally decay during passaging of the
epitope variant libraries. For each stop codon present above a threshold frequency of 10−4 in
the starting virus library, the frequency over time after passaging in the absence of CTLs is
plotted. Each value represents the average of experimental duplicates for each library.
(TIF)
S4 Fig. Numbers of SL9 epitope variants attaining various thresholds for enrichment by
CTLs. For each epitope variant (including immediately flanking residues) with initial library
frequencies above 10−4 in both replicates, first columns indicate relative enrichment versus
consensus without CTLs (RE-CTL), second columns indicate relative enrichment with added
CTLs (RE+CTL), and third columns indicate the difference (ΔRE) as in Fig 4. Fourth, fifth, and
sixth columns indicate variants achieving two-fold, five-fold, and ten-fold enrichment
(ΔRE 0.30, 0.70, or 1.0, respectively) by CTLs (open squares) or not (shaded squares).
(TIF)
S5 Fig. Numbers of KF11 epitope variants attaining various thresholds for enrichment by
CTLs. For each epitope variant (including immediately flanking residues) with initial library
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frequencies above 10−4 in both replicates, first columns indicate relative enrichment versus
consensus without CTLs (RE-CTL), second columns indicate relative enrichment with added
CTLs (RE+CTL), and third columns indicate the difference (ΔRE) as in Fig 4. Fourth, fifth, and
sixth columns indicate variants achieving two-fold, five-fold, and ten-fold enrichment
(ΔRE 0.30, 0.70, or 1.0, respectively) by CTLs (open squares) or not (shaded squares).
(TIF)
S6 Fig. Numbers of KK10 epitope variants attaining various thresholds for enrichment by
CTLs. For each epitope variant (including immediately flanking residues) with initial library
frequencies above 10−4 in both replicates, first columns indicate relative enrichment versus
consensus without CTLs (RE-CTL), second columns indicate relative enrichment with added
CTLs (RE+CTL), and third columns indicate the difference (ΔRE) as in Fig 4. Fourth, fifth, and
sixth columns indicate variants achieving two-fold, five-fold, and ten-fold enrichment
(ΔRE 0.30, 0.70, or 1.0, respectively) by CTLs (open squares) or not (shaded squares).
(TIF)
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